This is the authors' abstract. We don't add key points for this paper.
Reducing diagnostic delay is key toward decreasing tuberculosis-associated deaths in people living with human immunodeficiency virus. In tuberculosis patients with retrospective urine testing, the point-of-care Fujifilm SILVAMP TB LAM (FujiLAM) could have rapidly diagnosed tuberculosis in up to 89% who died. In FujiLAM negative patients, the probability of 12-week survival was 86-97%.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sossen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: